Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.

Yuko ShimaKoichi NakanishiYoshitsugu KakuKenji IshikuraHiroshi HatayaTakeshi MatsuyamaMasataka HondaMayumi SakoKandai NozuRyojiro TanakaKazumoto IijimaNorishige Yoshikawanull null

Published in: Pediatric nephrology (Berlin, Germany) (2018)

The balance between minimal benefits of warfarin/dipyridamole and potential adverse effects may be in favor of avoiding them in children with IgA nephropathy.

Keyphrases

combination therapy
atrial fibrillation
direct oral anticoagulants
venous thromboembolism
oral anticoagulants
young adults
early onset
human health
risk assessment
climate change